Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F56MN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $106,449
Award facts
- Contract value 100% obligated
- $106,448.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $106,448.52. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
Dupixent is a specialty biologic medication primarily indicated for treating atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. The supply of this branded pharmaceutical product supports the Defense Health Agency and broader military healthcare programs' ability to provide advanced treatment options to service members and beneficiaries. AmerisourceBergen's extensive portfolio of federal contract awards, predominantly with DLA's Medical Supply Chain, demonstrates the company's established capability to reliably distribute specialty pharmaceuticals and medical supplies to support military medical requirements.
Quick answers
Who was awarded contract SPE2DR26F56MN?
SPE2DR26F56MN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F56MN worth?
The government has obligated $106,449 on SPE2DR26F56MN.
Is contract SPE2DR26F56MN an order under another contract?
Yes. SPE2DR26F56MN is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56MN competed?
The extent of competition for SPE2DR26F56MN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award